GSK329
CAS No. 1268490-12-5
GSK329( GSK-329 | GSK 329 )
Catalog No. M27768 CAS No. 1268490-12-5
GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 132 | In Stock |
|
| 2MG | 66 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 183 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 439 | In Stock |
|
| 100MG | 597 | In Stock |
|
| 200MG | 804 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK329
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
-
DescriptionGSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK-329 | GSK 329
-
PathwayOthers
-
TargetOther Targets
-
Recptoramyloid-β| Caspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1268490-12-5
-
Formula Weight472.25
-
Molecular FormulaC19H14Cl2F3N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (211.75 mM)
-
SMILESCNc1cc(Oc2c(Cl)cc(cc2Cl)N(C(N)=O)c2cccc(c2)C(F)(F)F)ncn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ju Wang, et al. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model. Translational Neurodegeneration volume 10, Article number: 12 (2021).
molnova catalog
related products
-
Fluoromethalone
Fluorometholone is a corticosteroid, most often used after laser-based refractive surgery. It is marketed under the brand names FML (Allergan) and Flarex (Alcon).
-
TAS-102
TAS-102 is an investigational drug candidate for metastatic colorectal Y. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1.
-
Gymnemagenin
Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
Cart
sales@molnova.com